MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met-Reference-Cited by-同舟云学术

MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met

Published:2019-01 Issue: Volume:109 Page:1406-1410
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Gao Song,Zhao Zhiying,Wu Rong,Wu Lina,Tian Xin,Zhang Zhenyong

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference24 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016

2. PRL3 increases the aggressive phenotype of prostate cancer cells in vitro and its expression correlates with high-grade prostate tumors in patients;Edwards;Int. J. Oncol.,2018

3. Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches;Miyake;Int. J. Urol.,2013

4. The functions of animal microRNAs;Ambros;Nature,2004

5. MicroRNAs: genomics, biogenesis, mechanism, and function;Bartel;Cell,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bta-miR-330 promotes bovine intramuscular pre-adipocytes adipogenesis via targeting SESN3 to activate the Akt-mTOR signaling pathway;International Journal of Biological Macromolecules;2024-08

2. Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer;Cancer Letters;2024-04

3. Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms;Cancers;2023-06-10

4. Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges;Frontiers in Oncology;2023-03-07

5. Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer;Frontiers in Bioengineering and Biotechnology;2022-09-26